Pdt Partners, LLC Madrigal Pharmaceuticals, Inc. Transaction History

Pdt Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$60.57 - $79.51 $118,414 - $155,442	1,955 Added 42.79%	6,524 $424,000
Q2 2022 Aug 15, 2022	BUY	$58.04 - $100.2 $265,184 - $457,813	4,569 New	4,569 $327,000
Q1 2022 May 16, 2022	SELL	$55.89 - $101.89 $141,681 - $258,291	-2,535 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$72.34 - $95.09 $183,381 - $241,053	2,535 New	2,535 $215,000

297

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.37B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.